Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Blood Loss in Rivaroxaban Anticoagulated Pigs with Severe Polytrauma Is Significantly Reduced By Early Therapy with Prothrombin Complex Concentrate

Oliver Grottke, MD PhD MPH, Necib Akman, MD, Till Braunschweig, MD, Markus Honickel, MD, Hugo ten Cate, MD PhD

Blood (2017) 130 (Supplement 1): 2392.

https://doi.org/10.1182/blood.V130.Suppl_1.2392.2392

Published: 2017

Journal Articles

Markers of Thromboembolic Risk Were Insignificantly Affected By Either Intraosseous or Intravenous Idarucizumab in a Dabigatran-Anticoagulated Porcine Polytrauma Model

Markus Honickel, MD, Akman Necib, MD, Hugo ten Cate, MD PhD, Rolf Rossaint, MD Prof, Oliver Grottke, MD PhD

Blood (2016) 128 (22): 2623.

https://doi.org/10.1182/blood.V128.22.2623.2623

Published: 2016

Journal Articles

Prothrombin Complex Concentrate in Combination with Fibrinogen Plus Tranexamic Acid Is More Effective Than Mono-Therapy with Prothrombin Complex Concentrate in a Dabigatran Anticoagulation Experimental Polytrauma Model

Oliver Grottke, MD PhD, Markus Honickel, MD, Henri M.H. Spronk, PhD, Hugo ten Cate, Joanne van Ryn, PhD, Rolf Rossaint, MD

Blood (2014) 124 (21): 346.

https://doi.org/10.1182/blood.V124.21.346.346

Published: 2014

Journal Articles

Resuscitation With Different Volume Expanders Does Not Influence Coagulation After Antidoting Dabigatran With Its Specific Fab In a Pig Model Of Hemorrhagic Shock

Henri M.H. Spronk, PhD, Joanne van Ryn, PhD, Christian Zentai, Hugo ten Cate, MD, PhD, Rolf Rossaint, MD, Oliver Grottke, MD, PhD

Blood (2013) 122 (21): 3649.

https://doi.org/10.1182/blood.V122.21.3649.3649

Published: 2013

Journal Articles

Mouse Models of the Common, Recurring Type 1 von Willebrand Disease Mutations Y1584C and R1205H

Cynthia M. Pruss, PhD, Mia Golder, Andrea Bryant, Erin Burnett, Kate Sponagle, Carol Hegadorn, Sandra L. Haberichter, PhD, David Lillicrap, MD

Blood (2010) 116 (21): 22.

https://doi.org/10.1182/blood.V116.21.22.22

Published: 2010

Journal Articles

In Vitro and In Vivo Mouse Models of the Type 1 Von Willebrand Disease Mutations Y1584C and R1205H.

Cynthia M. Pruss, BSc, Kate Sponagle, Kimberly Laverty, Carol A. Hegadorn, Yvette Chirinian, Colleen Notley, Mia Golder, David Lillicrap, MD

Blood (2009) 114 (22): 26.

https://doi.org/10.1182/blood.V114.22.26.26

Published: 2009

Journal Articles

Recombinant Protein Infusion and Hydrodynamic Plasmid Delivery Strategies Provide Distinct and Complementary Approaches to the Characterization of Variant Forms of Von Willeband Factor (VWF) in VWF Knockout Mice.

Cynthia M. Pruss, BSc, Carol A. Hegadorn, Andrea Labelle, Erin Burnett, Mia Golder, David Lillicrap, MD

Blood (2008) 112 (11): 2020.

https://doi.org/10.1182/blood.V112.11.2020.2020

Published: 2008

NARROW

Blood Loss in Rivaroxaban Anticoagulated Pigs with Severe Polytrauma Is Significantly Reduced By Early Therapy with Prothrombin Complex Concentrate

Markers of Thromboembolic Risk Were Insignificantly Affected By Either Intraosseous or Intravenous Idarucizumab in a Dabigatran-Anticoagulated Porcine Polytrauma Model

Prothrombin Complex Concentrate in Combination with Fibrinogen Plus Tranexamic Acid Is More Effective Than Mono-Therapy with Prothrombin Complex Concentrate in a Dabigatran Anticoagulation Experimental Polytrauma Model

Resuscitation With Different Volume Expanders Does Not Influence Coagulation After Antidoting Dabigatran With Its Specific Fab In a Pig Model Of Hemorrhagic Shock

Mouse Models of the Common, Recurring Type 1 von Willebrand Disease Mutations Y1584C and R1205H

In Vitro and In Vivo Mouse Models of the Type 1 Von Willebrand Disease Mutations Y1584C and R1205H.

Recombinant Protein Infusion and Hydrodynamic Plasmid Delivery Strategies Provide Distinct and Complementary Approaches to the Characterization of Variant Forms of Von Willeband Factor (VWF) in VWF Knockout Mice.

Email alerts

ASH Publications

American Society of Hematology

Blood Loss in Rivaroxaban Anticoagulated Pigs with Severe Polytrauma Is Significantly Reduced By Early Therapy with Prothrombin Complex Concentrate

Markers of Thromboembolic Risk Were Insignificantly Affected By Either Intraosseous or Intravenous Idarucizumab in a Dabigatran-Anticoagulated Porcine Polytrauma Model

Prothrombin Complex Concentrate in Combination with Fibrinogen Plus Tranexamic Acid Is More Effective Than Mono-Therapy with Prothrombin Complex Concentrate in a Dabigatran Anticoagulation Experimental Polytrauma Model

Resuscitation With Different Volume Expanders Does Not Influence Coagulation After Antidoting Dabigatran With Its Specific Fab In a Pig Model Of Hemorrhagic Shock

Mouse Models of the Common, Recurring Type 1 von Willebrand Disease Mutations Y1584C and R1205H

In Vitro and In Vivo Mouse Models of the Type 1 Von Willebrand Disease Mutations Y1584C and R1205H.

Recombinant Protein Infusion and Hydrodynamic Plasmid Delivery Strategies Provide Distinct and Complementary Approaches to the Characterization of Variant Forms of Von Willeband Factor (VWF) in VWF Knockout Mice.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only